FUTUREBIOTICS INC
10-Q, EX-27, 2000-10-13
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: FUTUREBIOTICS INC, 10-Q, 2000-10-13
Next: ALL STAR GAS CORP, 10-K, 2000-10-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          NOV-30-2000
<PERIOD-END>                               AUG-31-2000
<CASH>                                              72
<SECURITIES>                                         0
<RECEIVABLES>                                    1,501
<ALLOWANCES>                                        12
<INVENTORY>                                        625
<CURRENT-ASSETS>                                 3,495
<PP&E>                                             478
<DEPRECIATION>                                     318
<TOTAL-ASSETS>                                   4,220
<CURRENT-LIABILITIES>                               14
<BONDS>                                              0
                                0
                                          1
<COMMON>                                             0
<OTHER-SE>                                       4,205
<TOTAL-LIABILITY-AND-EQUITY>                     4,220
<SALES>                                          4,833
<TOTAL-REVENUES>                                 4,833
<CGS>                                            3,099
<TOTAL-COSTS>                                    3,099
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  (478)
<INCOME-TAX>                                     (371)
<INCOME-CONTINUING>                              (107)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (107)
<EPS-BASIC>                                      (.12)
<EPS-DILUTED>                                    (.12)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission